Altamira Therapeutics Ltd. is incorporated under the laws of Bermuda.
Altamira Therapeutics Ltd.
Clarendon House
2 Church Street
Hamilton HM 11
Bermuda
The Altamira Therapeutics Ltd. ticker symbol is CYTO. Our shares are traded on the NASDAQ Capital Market.
The authorized share capital consists of 100,000,000 common shares, par value USD 0.002 each, and 20,000,000 preference shares, par value USD 0.0001 each.
As of October 25, 2024 there were 4,760,000 Pre-Funded Warrants outstanding, exercisable into 4,760,000 common shares.
We went public in 6 July 2014 with trading of our shares starting on August 6, 2014. The issue price was USD 6.00 per share.
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23,
New York, NY 10005
www.equinity.com
If your shares are held in “street name” and you wish to become a shareholder of record, you can instruct your broker-dealer to move your security position through the Direct Registration System (“DRS”) to Equiniti Trust Company, LLC (“EQ”), the Company’s transfer agent, for direct registration on the Company’s share register held with EQ. The DRS provides for electronic direct registration of securities in an investor's name on the books of a company with its transfer agent, and allows shares to be transferred between a transfer agent and broker electronically. If you later wish to sell your shares through your broker-dealer, you may instruct your broker-dealer to request that your shares be moved back to the broker-dealer through the DRS.
You can view our Board of Directors by visiting the Board of Directors section of our website.
You can view our management team by visiting the Management Team section of our website.
December 31
BDO AG, Zurich Switzerland
We have never paid or declared any cash dividends on our shares, and we do not anticipate paying any cash dividends on our common shares in the foreseeable future.
Quarterly and annual reports, as well as other SEC filings, can be accessed in the Financial Information section of our website or directly from the SEC at www.sec.gov.
You can reach Investor Relations by using our “Contact us” form.
In the United States, the vast majority of shares held by a broker or an agent of that broker are registered under the name of Cede & Co., as nominee for The Depository Trust Company (which acts as depositary and clearing house for many U.S. brokerage firms and custodian banks). If your shares are held in a stock brokerage account or otherwise by a broker, bank, trust or other nominee, then Cede & Co. is considered the record or registered holder and you are considered the beneficial owner of those shares, and your shares are said to be held in “street name.” Street name holders generally cannot vote their shares directly and must instead instruct their broker, bank, trust or other nominee how to vote their shares in connection with shareholder meetings.If your shares are registered directly in your name in the Company’s records, you are considered the shareholder of record with respect to those shares. Shareholders of record can vote their shares directly.
